Dr. Karim Chamie is a urologist specializing in urologic oncology, with a particular emphasis on bladder cancer. He offers comprehensive cancer care for patients with bladder, kidney, prostate, and testicular cancers. His research interests include studying factors driving the widespread underutilization of effective measures for patients with urological malignancies.
Bassett JC, Gore JL, Chi AC, Kwan L, McCarthy W, Chamie K, Saigal CS. Impact of a bladder cancer diagnosis on smoking behavior. J Clin Oncol. 2012 May 20;30(15):1871-8. Epub 2012 Apr 23.
Chamie K, Saigal CS, Lai J, Hanley JM, Setodji CM, Konety BR, Litwin MS; Urologic Diseases in America Project. Quality of care in patients with bladder cancer: a case report? Cancer. 2012 Mar 1;118(5):1412-21. doi: 10.1002/cncr.26402. Epub 2011 Aug 5.
Chamie K, Saigal CS, Lai J, Hanley JM, Setodji CM, Konety BR, Litwin MS; Urologic Diseases in America Project. Compliance with guidelines for patients with bladder cancer: variation in the delivery of care. Cancer. 2011 Dec 1;117(23):5392-401. doi: 10.1002/cncr.26198. Epub 2011 Jul 11.
Chamie K, Kurzrock EA, Evans CP, Litwin MS, Koppie TM, Wootton-Gorges SL, Boone JM, Lara PN Jr, Devere White RW. Secondary malignancies among nonseminomatous germ cell tumor cancer survivors. Cancer. 2011 Sep 15;117(18):4219-30. doi: 10.1002/cncr.26038. Epub 2011 Mar 15.
Chamie K, DeVere White RW, Lee D, Ok JH, Ellison LM. Agent Orange exposure, Vietnam War veterans, and the risk of prostate cancer. Cancer. 2008 Nov 1;113(9):2464-70.